What is Heartflow, Inc. Common Stock's revenue?

Heartflow, Inc. Common Stock (HTFL) generated $191.4M in revenue over the trailing twelve months, up 40.6% year over year.

Is Heartflow, Inc. Common Stock profitable?

Heartflow, Inc. Common Stock is not currently profitable: it reported a net loss of $111.8M over the trailing twelve months, a -58.4% net margin.

What are Heartflow, Inc. Common Stock's profit margins?

Gross margin is 78.1% and operating margin is -39.7%, with a -58.4% net margin.

What is Heartflow, Inc. Common Stock's earnings per share?

Heartflow, Inc. Common Stock's diluted EPS over the trailing twelve months is $-8.07.

Where does Heartflow, Inc. Common Stock's income statement data come from?

Every line is extracted from Heartflow, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Heartflow, Inc. Common Stock HTFL Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24
Total revenue	$176.04M+39.9%	$125.81M+44.3%
Total cost of revenue	$40.84M+30.2%	$31.36M+7.7%
Gross profit	$135.2M+43.1%	$94.45M+62.7%
Gross margin	76.8%+1.7pp	75.1%+8.5pp
Research and development	$64.92M+49.2%	$43.52M+21.4%
Selling, general and administrative	$134.35M+19.8%	$112.15M+17.9%
Selling and marketing	——	$14.47M+45.4%
General and administrative	——	$30.79M-3.1%
Compensation and benefits	——	$10.21M-14.0%
Occupancy and equipment	——	$4.9M-0.1%
Advertising	$2M+33.3%	$1.5M+92.8%
Depreciation and amortization	$5.44M+1.5%	$5.36M+12.9%
Provision for credit losses	——	-$244K-121%
Impairment charges	——	$0—
Other operating expenses	$341.71M+25.4%	$272.47M+18.9%
Total operating expenses	$199.26M+28.0%	$155.67M+18.9%
Operating income	-$64.07M-4.6%	-$61.22M+16.0%
Operating margin	-36.4%+12.3pp	-48.7%+35.0pp
Interest expense	$15.17M-33.4%	$22.77M-7.8%
Interest income	$5.54M+36.2%	$4.07M-25.5%
Other income (expense), net	-$68M-93.5%	-$35.15M-58.4%
Income before income taxes	-$209.17M-28.4%	-$162.87M+2.1%
Income tax expense	-$76K-155%	$138.25K-74.7%
Net income	-$116.79M-21.1%	-$96.43M-0.8%
Net margin	-66.3%+10.3pp	-76.6%+33.1pp
Preferred stock dividends	——	——
Diluted earnings per share	——	-$17.98+29.0%
Basic earnings per share	——	-$17.98+29.0%
Weighted-average shares, diluted	$98.44M+469%	$17.31M+102%
Weighted-average shares, basic	$98.44M+469%	$17.31M+102%
Royalty expense	——	$1.5M-28.6%
Foreign currency translation	——	-$269K-56.4%
Accretion (Amortization) of Discounts and Premiums, Investments	$1.68M—	——
Share-based compensation expense related to employee stock plans	——	$10.21M-14.0%
Pre-tax stock-based compensation cost	——	$10.21M-18.3%
Accounts Receivable, Allowance for Credit Loss, Writeoff	$188K-23.0%	$244K—
Amortization Of Financing Costs And Discounts	$5.37M+234%	$1.61M-42.1%
Stock options excluded as their inclusion would be anti-dilutive (in shares)	——	$132,416,324.00+0.2%
Debt securities, available-for-sale, unrealized loss	$15K—	——
Capital investments accrued but not yet paid	——	——
Software amortization expense	——	$3.7M+15.6%
Capitalized Contract Cost Amortization	$6.02M+61.0%	$3.74M+68.7%
Capitalized Contract Costs Capitalized	$10.8M+55.3%	$6.95M+126%
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$116.44M-20.4%	-$96.7M-0.6%
Contract With Customer Liability Additions	$279K—	——
Revenue recognized that was included in deferred income at the beginning of the period	$134K-57.6%	$316K+251%
Conversion Of Convertible Note Into Redeemable Convertible Preferred Stock	——	——
Convertible Debt Increase Decrease In Fair Value	——	——
Convertible Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction	——	——
Debt Conversion Debt Issuance Costs Reclassified To Additional Paid In Capital	——	——
Debt Conversion Derivative Liability Reclassified To Additional Paid In Capital	——	——
Debt Conversion Original Debt Amount1	——	——
Debt Instrument Conversion Price Discount Percentage	——	——
Credit losses on securities without previous credit losses	$0—	——
Gain (loss) on available-for-sale debt securities	——	——
Deemed Dividend Upon Down Round Of Redeemable Convertible Preferred Stock	——	——
Defined Contribution Plan Cost Recognized	——	$1.5M+7.1%
Defined Contribution Plan Employer Matching Contribution Percent	——	——
Maximum percentage of annual compensation contributed by the participant (percent)	——	——
Dividends, Common Stock	$0—	——
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash	$451K—	——
Income taxes at U.S. statutory rate of 21%	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——
Foreign operations	——	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Mark To Market Warrant And Derivativ Amount	$7.68M+121%	$3.48M+224%
Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation Amount	$1.24M—	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Write Off Of Intercompany Payable	——	——
Other	-$0.02—	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Executive Compensation	——	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Mark To Market Warrant And Derivative	——	——
Effective Income Tax Rate Reconciliation Tax Credits Research	——	——
Effective Income Tax Rate Rreconciliation Nondeductible Expense Write Off Of Intercompany Payable Amount	$4.76M—	——
Federal State And Local Income Tax Expense Benefit Continuing Operations	——	——
Foreign Income Tax Expense Benefit Continuing Operations	——	——
Impairment charge on leasehold improvements	——	——
Impairment Of Long Lived Assets Held For Use	——	$0—
Income Loss From Continuing Operations Before Income Taxes Domestic	——	——
Income Loss From Continuing Operations Before Income Taxes Foreign	——	——
Income Tax Examination Year Under Examination	$2.02K—	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	$6.32M-61.9%	$16.56M-18.9%
Income Tax Reconciliation Foreign Income Tax Rate Differential	——	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	——
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	$2.62M—	——
Share-based compensation	——	$1.71M-54.2%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	$1.03M+26.1%	$816K+525%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	-$2.25M+44.3%
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	$382K+35.9%	$281K-28.1%
Income taxes paid	$0—	——
Accounts payable	——	-$327K+47.5%
Increase (Decrease) in Accounts Receivable	——	$3.85M-58.8%
Short- and long-term operating lease liabilities	-$3.72M-15.4%	-$3.22M-82.7%
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	——	$426K-88.7%
Increase (decrease) in other assets	——	$2.7M+571%
Increase (decrease) in all other liabilities	$89K+141%	-$215K-213%
Increase (Decrease) in Prepaid Expense and Other Assets	$7.94M+696%	$998K+180%
Increase Decrease In Right Of Use Assets And Lease Obligation Related To Amedment Of Lease Terms	——	——
Interest Paid, Excluding Capitalized Interest, Operating Activity	$8.57M-55.3%	$19.16M-7.9%
Lease Cost	——	$6.5M+7.8%
Lessee Operating Lease Number Of Renewal Options	——	——
Long-term material purchase obligations	$5.2M—	——
Marketing	$19.15M+32.3%	$14.47M+45.4%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	——	$2.24M-98.7%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$238.57M-5,376%	-$4.36M+28.6%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	-$54.02M+21.7%	-$69M+9.7%
Non Cash Interest Charges	——	$2.02M+133%
Number of operating segments	1—	——
Number of reportable segments	1—	——
Offering Costs Incurred During Noncash Or Partial Noncash Transaction	——	$413K—
Lease impairment	——	——
Operating Lease Payments	——	$5.2M+26.8%
Operating lease right-of-use assets amortization expense	$3.13M+14.6%	$2.74M-5.3%
Foreign currency translation	——	-$271K+46.2%
Other comprehensive income/(loss)	$347K+228%	-$271K+46.2%
Other income, net (Note 6)	-$223K-126%	$854K+163%
Paid-in-kind interest capitalized	——	——
Payment Of Deferred Offering Costs	——	——
Payments for Repurchase of Common Stock	——	——
Payments Of Debt Extinguishment Costs	——	$2.33M—
Payment, Tax Withholding, Share-Based Payment Arrangement	$510K—	——
Payments to Acquire Investments	$233.54M—	——
Payments to Acquire Property, Plant, and Equipment	$5.03M+15.3%	$4.36M-28.6%
Preferred Stock Convertible Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount	——	——
Maturities of convertible senior notes	——	——
Proceeds From Income Tax Refunds	——	$72K—
Proceeds From Issuance Initial Public Offering	$332.39M—	——
Proceeds from Issuance of Common Stock	——	——
Proceeds From Issuance Of Redeemable Convertible Preferred Stock	——	——
Proceeds from disposition of marketable securities and other investments	——	——
Cash received from option exercises	$3.3M-27.7%	$4.56M+675%
Net additions (releases) charged to costs and expenses	$188K+177%	-$244K-121%
Reclassification Of Warrant Liability To Common Stock Upon Net Exercise	$64.73M—	——
Reclassifications Of Debt	——	——
Redeemable Preferred Stock Dividends	——	——
Regulatory And Clinical Expense	$26.25M+49.7%	$17.53M+29.7%
Research And Development Expense Other Than Regulatory And Clinical Expense	$38.67M+48.8%	$25.98M+16.4%
Revenue From Contract With Customer Excluding Assessed Tax	$176.04M+39.9%	$125.81M+44.3%
Selling Expense	$75.71M+13.2%	$66.9M+25.3%
Stock-based compensation	$13.97M+36.7%	$10.21M-14.0%
Granted (in shares)	$2.55M—	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period	——	——
Forfeited or expired (in shares)	——	——
Granted (in shares)	——	——
Exercised (in shares)	——	——
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1	$8.6M+330%	$2M-37.5%
Stock Issued During Period Shares Conversion Of Convertible Securities	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	$617.13K—	——
Stock Issued During Period, Value, Conversion of Convertible Securities	$768.57M—	——
Stock Issued During Period Value Conversion Of Convertible Debt	$94.14M—	——
Stock issued for employee stock purchase plan	——	——
Stock Issued During Period Value Exercise Of Warrants	$64.73M—	——
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment	$332.39M—	——
Issuance of vested restricted stock units	-$510K—	——
Stock Issued During Period, Value, Stock Options Exercised	——	$4.56M+675%
Stock Option Exercise Price Change Additional Compensation Per Share	——	——
Stock Option Exercise Price Change Aggregate Additional Compensation Expense	——	——
Stock Option Exercise Price Change Aggregate Additional Compensation Expense Recognized Immediately	——	——
Purchase price	——	——
Stock split, conversion ratio (in shares)	——	——
Temporary Equity Conversion Of Preferred Stock To Common Stock Upon Ipo Value	$768.57M—	——
Change in fair value of interest rate swap	$7.31M—	——
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions	——	$149K—
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions	$552K-1.1%	$558K-31.7%
Additions for tax positions of prior years	$75K—	——
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$1.6M-90.5%	$16.8M-17.6%
Valuation Allowance Deferred Tax Asset Decrease Amount	$3.79M—	——
Valuation Allowance Deferred Tax Asset Increase Amount	$5.35M-68.2%	$16.82M-17.7%
Variable Lease Cost	——	$1.6M+42.6%
EBIT	-$64.07M-4.6%	-$61.22M+16.0%
EBITDA	-$58.63M-5.5%	-$55.56M+18.5%
EBITDA	-$58.63M-5.5%	-$55.56M+18.5%
EBITDA margin	-33.3%+10.9pp	-44.2%+34.0pp
EBIT	-$64.07M-4.6%	-$61.22M+16.0%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Heartflow, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Heartflow, Inc. Common Stock's revenue?: Heartflow, Inc. Common Stock (HTFL) generated $191.4M in revenue over the trailing twelve months, up 40.6% year over year.
Is Heartflow, Inc. Common Stock profitable?: Heartflow, Inc. Common Stock is not currently profitable: it reported a net loss of $111.8M over the trailing twelve months, a -58.4% net margin.
What are Heartflow, Inc. Common Stock's profit margins?: Gross margin is 78.1% and operating margin is -39.7%, with a -58.4% net margin.
What is Heartflow, Inc. Common Stock's earnings per share?: Heartflow, Inc. Common Stock's diluted EPS over the trailing twelve months is $-8.07.
Where does Heartflow, Inc. Common Stock's income statement data come from?: Every line is extracted from Heartflow, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.